Both in Pharmaceuticals
NanoViricides vs Impact BioMedical
Over the past year NNVC returned −13.7% and IBO returned −52.8%; their daily moves had a correlation of -0.06.
NNVC −13.7% IBO −52.8%Growth of $1, one year, split-adjusted
| Metric | NNVC | IBO |
|---|---|---|
| Price | $1.39 | $3.47 |
| Market cap | $35.5M | $29.6M |
| Today | −0.71% | −3.61% |
| 1 month | −3.5% | −39.0% |
| 6 months | +11.2% | −58.3% |
| Year to date | +23.0% | −45.6% |
| 1 year | −2.9% | −52.9% |
| Revenue growth (YoY) | — | −57.1% |
| Gross margin | — | −533.3% |
| Net margin | — | −23300.0% |
| P/E (TTM) | — | 37.6× |
| Price / sales | — | 847.0× |
| Net cash | $2.8M | $10.0K |
| Dividend yield | — | — |
| Volatility (60d) | 87.8% | 736.1% |
| Short % of float | 3.7% | 0.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).